Panel Discussion: Establishing Multistakeholder-Relevant Clinical Endpoints

Time: 11:30 am
day: Clinical - AM


  • How can we ensure clinical trial endpoints are meaningful to patients, agreeable to regulators, and measurable to payers
  • Considerations for internal team structuring to ensure endpoints are relevant to all stakeholders
  • Understanding EMA and FDA differences in deeming an outcome ‘clinically meaningful’